GUIDETTI, ANNA
GUIDETTI, ANNA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin®)
2009-01-01 C. Chiesa, F. Botta, A. Coliva, M. Maccauro, L. Devizzi, A. Guidetti, C. Carlo-Stella, E. Seregni, A.M. Gianni, E. Bombardieri
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone (rhGH)
2004-01-01 C. Carlo-Stella, M. Di Nicola, R. Milani, P. Longoni, M. Milanesi, C. Bifulco, C. Stucchi, A. Guidetti, L. Cleris, F. Formelli, G. Garotta, A.M. Gianni
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma
2021-05-03 R.W. Merryman, L. Castagna, L. Giordano, V.T. Ho, P. Corradini, A. Guidetti, B. Casadei, D.A. Bond, S. Jaglowski, M.A. Spinner, S. Arai, R. Lowsky, G.L. Shah, M.-. Perales, J.M.S. De Colella, D. Blaise, A.F. Herrera, G. Shouse, C. Spilleboudt, S.M. Ansell, Y. Nieto, T. Badar, M. Hamadani, T.A. Feldman, L. Dahncke, A.K. Singh, J.P. McGuirk, T. Nishihori, J. Chavez, A.V. Serritella, J. Kline, M. Mohty, R. Dulery, A. Stamatoulas, R. Houot, G. Manson, M.-. Moles-Moreau, C. Orvain, K. Bouabdallah, D. Modi, R. Ramchandren, L. Lekakis, A. Beitinjaneh, M.J. Frigault, Y.-. Chen, R.C. Lynch, S.D. Smith, U. Rao, M. Byrne, J.T. Romancik, J.B. Cohen, S. Nathan, T. Phillips, R.M. Joyce, M. Rahimian, A. Bashey, H.J. Ballard, J. Svoboda, V. Torri, M. Sollini, C. De Philippis, M. Magagnoli, A. Santoro, P. Armand, P.L. Zinzani, C. Carlo-Stella
Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma : long-term outcomes and graft-versus-host disease-free/relapse-free survival
2018-05-01 F. Spina, T. Radice, C. De Philippis, M. Soldarini, M.C. Di Chio, A. Dodero, A. Guidetti, S. Viviani, P. Corradini
Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?
2019-10-01 A. Chiappella, J. Crombie, A. Guidetti, U. Vitolo, P. Armand, P. Corradini
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34+-derived dendritic cell vaccination: a phase I trial in metastatic melanoma
2004-08-15 M. Di Nicola, C. Carlo-Stella, R. Mortarini, P. Baldassari, A. Guidetti, F. Gallino, M. Del Vecchio, F. Ravagnani, M. Magni, P. Chaplin, N. Cascinelli, G. Parmiani, A. Gianni, A. Anichini
CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice
2006-01-01 C. Carlo-Stella, A. Guidetti, M. Di Nicola, P. Longoni, L. Cleris, C. Lavazza, M. Milanesi, R. Milani, M. Carrabba, L. Farina, F. Formelli, A.M. Gianni, P. Corradini
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics
2022-04-25 E. Calabretta, A. Guidetti, F. Ricci, M. Di Trani, C. Monfrini, M. Magagnoli, S. Bramanti, D. Maspero, L. Morello, M. Merli, A. Di Rocco, A. Graudenzi, E. Derenzini, M. Antoniotti, D. Rossi, P. Corradini, A. Santoro, C. Carlo-Stella
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34+ cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trial
2003-01-01 M. Di Nicola, C. Carlo-Stella, A. Anichini, R. Mortarini, A. Guidetti, G. Tragni, F. Gallino, M. Del Vecchio, F. Ravagnani, D. Morelli, P. Chaplin, N. Arndtz, G. Sutter, I. Drexler, G. Parmiani, N. Cascinelli, A.M. Gianni
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation : Life-threating Features Within the Early Post-engraftment Phase
2020-08-01 C. Oltolini, A. Guidetti, M. Ripa, B. Castiglioni, C. Tassan Din, S. Mastaglio, D. Canetti, G. Monti, A. Andolina, C. Molinari, A. Poloniato, A. Mastrangelo, M. Ferrante, M. Lanzillotta, P. Scarpellini, A. Castagna, P. Corradini, F. Ciceri
COVID-19 and CAR-T cells: current challenges and future directions-a report from the EPICOVIDEHA survey by EHA-IDWP
2021-01-01 A. Busca, J. Salmanton-García, P. Corradini, F. Marchesi, A. Cabirta, R. Di Blasi, R. Dulery, S. Lamure, F. Farina, B. Weinbergerová, J. Batinić, A. Nordlander, A. Lopez-Garcia, L. Drgona, I. Espigado, I. Falces-Romero, R. Garcia-Sanz, C. Garcia-Vidal, A. Guidetti, N. Khanna, A. Kulesekararaj, J. Maertens, M. Hoenigl, N. Klimko, P. Koehler, A. Pagliuca, F. Passamonti, O. Cornely, L. Pagano
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
2021-10-14 L. Pagano, J. Salmanton-Garcia, F. Marchesi, A. Busca, P. Corradini, M. Hoenigl, N. Klimko, P. Koehler, A. Pagliuca, F. Passamonti, L. Verga, B. Visek, O. Ilhan, G. Nadali, B. Weinbergerova, R. Cordoba-Mascunano, M. Marchetti, G.P. Collins, F. Farina, C. Cattaneo, A. Cabirta, M. Gomes-Silva, F. Itri, J. van Doesum, M.-. Ledoux, M. Cernan, O. Jaksic, R.F. Duarte, G. Magliano, A.S. Omrani, N.S. Fracchiolla, A. Kulasekararaj, T. Valkovic, C.B. Poulsen, M. Machado, A. Glenthoj, I. Stoma, Z. Racil, K. Piukovics, M. Navratil, Z. Emarah, U. Sili, J. Maertens, O. Blennow, R. Bergantim, C. Garcia-Vidal, L. Prezioso, A. Guidetti, M.I. del Principe, M. Popova, N. de Jonge, I. Ormazabal-Velez, N. Fernandez, I. Falces-Romero, A. Cuccaro, S. Meers, C. Buquicchio, D. Antic, M. Al-Khabori, R. Garcia-Sanz, M.M. Biernat, M.C. Tisi, E. Sal, L. Rahimli, N. Colovic, M. Schonlein, M. Calbacho, C. Tascini, C. Miranda-Castillo, N. Khanna, G.-. Mendez, V. Petzer, J. Novak, C. Besson, R. Dulery, S. Lamure, M. Nucci, G. Zambrotta, P. Zak, G.C. Seval, V. Bonuomo, J. Mayer, A. Lopez-Garcia, M.V. Sacchi, S. Booth, F. Ciceri, M. Oberti, M. Salvini, M. Izuzquiza, R. Nunes-Rodrigues, E. Ammatuna, A. Obr, R. Herbrecht, L. Nunez-Martin-Buitrago, V. Mancini, H. Shwaylia, M. Sciume, J. Essame, M. Nygaard, J. Batinic, Y. Gonzaga, I. Regalado-Artamendi, L.K. Karlsson, M. Shapetska, M. Hanakova, S. El-Ashwah, Z. Borbenyi, G.M. Colak, A. Nordlander, G. Dragonetti, A.M.E. Maraglino, A. Rinaldi, C. De Ramon-Sanchez, O.A. Cornely, O. Finizio, R. Fazzi, G. Sapienza, A. Chauchet, J. Van Praet, J. Prattes, M. Dargenio, C. Rossi, A. Shirinova, S. Malak, A. Tafuri, H.-. Ommen, S. Bologna, R.A. Khedr, S. Choquet, B. Joly, M.M. Ceesay, L. Philippe, C.S. Kho, M. Desole, P. Tsirigotis, V. Otasevic, D.M.M. Borducchi, A. Antoniadou, J. Gaziev, M.A. Almaslamani, N. Garcia-Pouton, G. Paterno, A. Torres-Lopez, G. Tarantini, S. Mellinghoff, S. Grafe, N. Borschel, J. Passweg, M. Merelli, A. Barac, D. Wolf, M.U. Shaikh, C. Thieblemont, S. Bernard, V.A.M. Funke, E. Daguindau, S. Khostelidi, F.M. Nucci, J.-. Martin-Gonzalez, M. Landau, C. Soussain, C. Laureana, K. Lacombe, M. Kohn, G. Aliyeva, M. Piedimonte, G. Fouquet, M. Rego, B. Hoell-Neugebauer, G. Cartron, F. Pinto, A.M. Alburquerque, J. Passos, A.F. Yilmaz, A.-. Redondo-Izal, F. Altuntas, C. Heath, M. Kolditz, E. Schalk, F. Guolo, M. Karthaus, R. Della Pepa, D. Vinh, N. Noel, B. Deau Fischer, B. Drenou, M.E. Mitra, J. Meletiadis, Y.M. Bilgin, P. Jindra, I. Espigado, L. Drgona, A. Serris, R. Di Blasi, N. Ali
Cytokine secretion associated with the clearance of apoptotic bodies in renal cell carcinoma patients
2001-03-20 A. Bondanza, P. Rovere, A. Borri, E.R. Caremoli, A. Guidetti, G. Citterio, G. Consogno, V.S. Zimmermann, C. Rugarli, A.A. Manfredi
Detection of minimal residual disease in hematopoietic progenitor cell harvests : lack of predictive value of peripheral blood and bone marrow analysis in mantle cell and indolent lymphoma
2012-01-01 M. Magni, M.D. Nicola, C. Carlo-Stella, P. Matteucci, L. Devizzi, A. Guidetti, F. Ravagnani, A.M. Gianni
Dose-Adjusted Epoch and Rituximab for the treatment of double expressor and double hit diffuse large B-cell lymphoma: impact of TP53 mutations on clinical outcome
2021-01-01 A. Dodero, A. Guidetti, F. Marino, A. Tucci, F. Barretta, A. Re, M. Balzarotti, C. Carniti, C. Monfrini, A. Chiappella, A. Cabras, F. Facchetti, M. Pennisi, D. Rahal, V. Monti, L. Devizzi, R. Miceli, F. Cocito, L. Farina, F. Ricci, G. Rossi, C. Carlo-Stella, P. Corradini
Dose-adjusted EPOCH plus rituximab improves the clinical outcome of young patients affected by double expressor diffuse large B-cell lymphoma
2019-01-01 A. Dodero, A. Guidetti, A. Tucci, F. Barretta, M. Novo, L. Devizzi, A. Re, A. Passi, A. Pellegrinelli, G. Pruneri, R. Miceli, A. Testi, M. Pennisi, M.C. Di Chio, P. Matteucci, C. Carniti, F. Facchetti, G. Rossi, P. Corradini
Dosimetry in myeloablative (90)Y-labeled ibritumomab tiuxetan therapy : possibility of increasing administered activity on the base of biological effective dose evaluation. Preliminary results.
2007-01-01 C. Chiesa, F. Botta, E. Di Betta, A. Coliva, M. Maccauro, G. Aliberti, S. Bavusi, L. Devizzi, A. Guidetti, E. Seregni, A.M. Gianni, E. Bombardieri
Early reduction of serum TARC levels may predict for success of ABVD as frontline treatment in patients with Hodgkin Lymphoma
2017-11-01 A. Guidetti, M. A., M. R., E.V.M. Paterno', T. F., S. F., C. F., F. L., P. Corradini, G. A. M., V. S.
Early Serum TARC Reduction Predicts Prognosis in Advanced-Stage Hodgkin Lymphoma Patients Treated with a PET-Adapted Strategy
2020-01-01 S. Viviani, A. Mazzocchi, C. Pavoni, F. Taverna, A. Rossi, C. Patti, A. Romano, L. Trentin, R. Sorasio, A. Guidetti, D. Gottardi, C. Tarella, M. Cimminiello, R. Zanotti, L. Farina, A.J.M. Ferreri Ajm, M. Galbiati, P. Corradini, A.M. Gianni, A. Gallamini, A. Rambaldi
Efficacy and safety of high-dose chemotherapy with in vivo purged auto-SCT in relapsed follicular lymphoma : long-term follow-up
2010-06-01 M. Magni, M. Di Nicola, C. Carlo Stella, L. Devizzi, A. Guidetti, P. Matteucci, A. Gianni